PROTAC vaccine: A new way to live attenuated vaccines-Reference-Cited by-同舟云学术

PROTAC vaccine: A new way to live attenuated vaccines

Published:2022-10 Issue:10 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Li Zhen¹,Bai Haiqing²,Xi Xuetong¹³,Tian Wen‐xia⁴,Zhang John Z.H.¹,Zhou Demin⁵,Si Longlong¹³

Affiliation:

1. CAS Key Laboratory of Quantitative Engineering Biology Shenzhen Institute of Synthetic Biology Shenzhen Institute of Advanced Technology Chinese Academy of Sciences Shenzhen China

2. Xellar Biosystems Inc Cambridge Massachusetts USA

3. College of Life Sciences University of Chinese Academy of Sciences Beijing China

4. College of Veterinary Medicine Shanxi Agricultural University Jinzhong China

5. State Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences Peking University Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1081

Reference11 articles.

1. Current and future influenza vaccines

2. Generation of a live attenuated influenza A vaccine by proteolysis targeting

3. Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics

4. Live attenuated influenza virus vaccines by computer-aided rational design

5. Generation of influenza A viruses as live but replication-incompetent virus vaccines

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics;Vaccines;2024-08-01

2. PROTAC Beyond Cancer- Exploring the New Therapeutic Potential of Proteolysis Targeting Chimeras;Current Topics in Medicinal Chemistry;2024-07-03

3. PROTACs: A novel strategy for cancer drug discovery and development;MedComm;2023-05-29